Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study

Elena Elimova, Jaffer A. Ajani, Howard A. Burris, Crystal S. Denlinger, S. Iqbal, Yoon‐Koo Kang, Jwa Hoon Kim, Keun Wook Lee, Bruce Lin, Rutika Mehta, Do‐Youn Oh, Sun Young Rha, Young Mi Seol, Lin Yang, Mark A. Ozog, Phillip M. Garfin, Geoffrey Ku